Catalog |
name |
Description |
price |
R-M-1836 |
Z-VRPR-FMK TFA |
Z-VRPR-FMK (TFA) (VRPR), a tetrapeptide, is a selective and irreversible MALT1 (Mucosa-associated lymphoid tissue lymphoma translocation protein 1) inhibitor. Z-VRPR-FMK (TFA) can protect against influenza A virus (IAV) infection. |
price> |
R-M-1841 |
Ziconotide acetate,cas:914454-03-8 |
Ziconotide acetate (SNX-111 acetate), a peptide, is a potent and selective block of N-type calcium channels antagonist. Ziconotide acetate reduces synaptic transmission, and can be used for chronic pain research. |
price> |
R-M-1842 |
M617 TFA |
M617 TFA is a selective galanin receptor 1 (GAL1) agonist, with Kis of 0.23 and 5.71 nM for GAL1 and GAL2, respectively. M617 TFA, acting through its central GAL1, can promote GLUT4 expression and enhance GLUT4 content in the cardiac muscle of type 2 diabetic rats. |
price> |
R-M-1843 |
Activated Protein C (390-404), human,cas:146340-20-7 |
Activated Protein C (390-404), human is a peptide of the activated protein C (a vitamin K-dependent serine protease), potently inhibits APC anticoagulant activity. |
price> |
R-M-1844 |
IYPTNGYTR acetate |
IYPTNGYTR acetate, a deamidation-sensitive signature peptide, is a deamidation product of Trastuzumab. IYPTNGYTR acetate can be used to monitor in vivo Trastuzumab metabolism. |
price> |
R-M-1845 |
DAPK Substrate Peptide TFA |
DAPK Substrate Peptide TFA is a synthetic peptide substrate for death associated protein kinase (DAPK), with a Km of 9 μM. |
price> |
R-M-1850 |
LRGILS-NH2 TFA |
LRGILS-NH2 TFA is a reverse-sequence protease-activated receptor-2 (PAR-2)-inactive, negative control, and SLIGRL-NH2 is a PAR-2-activating peptide. |
price> |
R-M-1858 |
DLPLTFGGGTK TFA |
DLPLTFGGGTK (TFA) is a surrogate peptide for pembrolizumab identification. |
price> |
R-M-1859 |
BIM-23190 hydrochloride |
BIM-23190 hydrochloride, a somatostatin analog, a selective SSRT2 and SSRT5 agonist, exhibits Ki values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly. |
price> |
R-M-1860 |
M2e, human TFA |
M2e, human TFA, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A. M2e, human TFA is a valid and versatile vaccine candidate to protect against any strain of human influenza A. |
price> |